TAPI and Sagimet Biosciences Announce Global License Agreement
18 Dec 2025 //
PRESS RELEASE
Sanofi`s Efdoralprin Alfa Granted EU Orphan Designation
18 Dec 2025 //
PRESS RELEASE
Q4 2025 Aide-Mémoire Now Available
18 Dec 2025 //
PRESS RELEASE
Voyager Jettisons Staff, Novartis Hands Back 2 Programs
18 Dec 2025 //
FIERCE BIOTECH
Novartis Builds Largest Global R&D Hub In India
18 Dec 2025 //
ECONOMICTIMES
Lupin Receives Positive CHMP Opinion For Biosimilar Ranibizumab
18 Dec 2025 //
PRESS RELEASE
Lupin Receives EIR from US FDA for its Nagpur Injectable Facility
18 Dec 2025 //
PRESS RELEASE
Vistagen`s Social Anxiety Disorder Asset Stumbles In Phase 3
18 Dec 2025 //
BUSINESSWIRE
Alnylam Drafts $250 M Upgrade to Its Mass. Drug Factory
18 Dec 2025 //
BUSINESSWIRE
Drugs In Development
Market Intel

Market Place
Sourcing Support